Target intelligence / Profile preview

MicroRNA 525 (miR-525)

Target
miR-525
Molecular classification
Other (non-coding RNA, microRNA)
01

Overview

MicroRNA 525 (miR-525) is a short, non-coding RNA molecule classified as a microRNA, encoded on human chromosome 19. miR-525 regulates gene expression post-transcriptionally by base-pairing with specific mRNA targets, leading to repression or degradation of those transcripts. Functionally, miR-525 acts in diverse biological contexts as a regulator of cell proliferation, apoptosis, migration, and invasion. In several cancers, miR-525 can serve either as a tumor suppressor (by targeting F-spondin 1 and inhibiting downstream oncogenic pathways like FAK/Src/PI3K/Akt) or an oncogene (promoting migration/invasion in liver cancer by targeting ZNF395)[2][3][4][5]. Expression levels of miR-525 are abnormally regulated in various diseases (e.g., cancers, osteoarthritis), and it is being actively studied for its clinical utility as a biomarker and as a therapeutic target, especially for improving the efficacy of radiotherapy[4][6].

Other names
hsa-mir-525MIRN525MIR525microRNA-525-3pmiR-525-5p
02

Mechanism of action

Experimental approaches include: - Use of miR-525 mimics to suppress tumor cell migration/invasion and promote apoptosis[2][3] - Use of miR-525 inhibitors to activate oncogenic signaling (by derepressing SPON1, for instance)[2][3] - Modulation of miR-525 activity to enhance sensitivity to radiation[6]

03

Biological functions

Regulation of cell migrationRegulation of cell invasionRegulation of apoptosisModulation of signaling pathways (FAK/Src/PI3K/Akt, NF-κB)Post-transcriptional gene silencingCell survival/homeostasis
04

Disease associations

Cancer (chondrosarcoma, diffuse large B-cell lymphoma, liver cancer, prostate cancer)OsteoarthritisRadiation response
05

Safety considerations

Potential off-target effects and immune responses when manipulating miRNA levels as a therapyChallenges in delivery and specificity for therapeutic miRNA targeting
06

Biomarkers

miR-525 expression levels as a diagnostic and prognostic biomarker in several cancersmiR-525-3p levels for patient selection or efficacy monitoring in liver and germ cell cancers, and osteoarthritis

Beyond the preview

Go deeper on MicroRNA 525 (miR-525).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 525 (miR-525).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call